(Q41673708)

English

Reversal of ferritin-mediated immunosuppression by Levamisole: a rationale for its application to management of the acquired immune deficiency syndrome (AIDS)

scientific article published on February 1, 1995

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Reversal of ferritin-mediated immunosuppression by Levamisole: a rationale for its application to management of the acquired immune deficiency syndrome (AIDS) (English)

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

immunosuppression

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J. M. Wigginton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7596311

3 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7596311

3 June 2024

publication date

1 February 1995

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0306987795900756?httpAccept=text/xml

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

https://api.elsevier.com/content/article/PII:0306987795900756?httpAccept=text/plain

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Medical Hypotheses

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

85-88

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Detection of a glycosylated subunit in human serum ferritin

2

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Binding of Human Serum Ferritin to Concanavalin A

3

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Turnover of 131I-human spleen ferritin in plasma

4

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Characterization of serum ferritin in iron overload: possible identity to natural apoferritin

6

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Ferritin: structure, biosynthesis, and role in iron metabolism

7

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Differential effect of isolated placental isoferritins on in vitro T-lymphocyte function

9

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

In vitro suppression of cell-mediated immunity by ferroproteins and ferric salts

10

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Suppressive Effect of Ferritin on in Vitro Lymphocyte Function

11

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Ferritin selectively suppresses delayed-type hypersensitivity responses at induction or effector phase

12

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Inhibitory effects of isoferritins from tumour and non-tumour tissues on E-rosette formation

13

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Isoferritins in HIV infection

15

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Phenomenon of human T cells rosetting with sheep erythrocytes analyzed with monoclonal antibodies. "Modulation" of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytes

19

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors"

20

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand

23

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

The potential role of serum ferritin in the pathogenesis of acquired immune deficiency syndrome (AIDS).

28

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Effect of Levamisole on E-Rosette-Forming Cells in Vivo and in Vitro in Hodgkin's Disease

30

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Restoration of cellular immune response by levamisole in patients with Hodgkin's disease

31

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels

33

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Restoration by levamisole of immune responses suppressed in tumor-bearing mice

35

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Restoration of immune response by levamisole in B-77 virus induced tumor-bearing rats

36

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Levamisole in advanced human breast cancer

37

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Drug-Induced Restoration of Cutaneous Delayed Hypersensitivity in Anergic Patients with Cancer

38

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole

39

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Effects of Levamisole on In Vivo and In Vitro Murine Host Response to Syngeneic Transplantable Tumor2

40

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test

42

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Depletion of Thymus Dependent Lymphocytes in Hodgkin's Disease

43

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Urinary estrogen excretion in men with advanced cancer.

44

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Levamisole treatment in HIV-infected Zambian children

45

1 reference

10.1016/0306-9877(95)90075-6

https://api.crossref.org/works/10.1016/0306-9877(95)90075-6

3 June 2024

Identifiers

10.1016/0306-9877(95)90075-6

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41673708&oldid=2171564477"